Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1994 2
1995 3
1996 3
1997 3
1998 2
1999 6
2000 8
2001 6
2002 2
2003 5
2004 3
2005 8
2006 3
2007 5
2008 7
2009 6
2010 8
2011 5
2012 6
2013 10
2014 11
2015 10
2016 5
2017 8
2018 9
2019 10
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Results by year
Filters applied: . Clear all
Page 1
PBC-transplantation and disease recurrence.
Nevens F. Nevens F. Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:107-111. doi: 10.1016/j.bpg.2018.09.001. Epub 2018 Sep 11. Best Pract Res Clin Gastroenterol. 2018. PMID: 30343704 Review.
For the appropriate timing of LT the utility of prognostic models (bilirubin, Mayo risk score and MELD, in particular) and standard exception points in case of HCC are established. ...Therefore biomarkers after LT that may identify patients at risk for …
For the appropriate timing of LT the utility of prognostic models (bilirubin, Mayo risk score and MELD, in particular) …
Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score.
Khoshpouri P, Ameli S, Ghasabeh MA, Pandey A, Zarghampour M, Varzaneh FN, Jacob A, Pandey P, Luo Y, Kamel IR. Khoshpouri P, et al. Eur J Radiol. 2018 Nov;108:254-260. doi: 10.1016/j.ejrad.2018.10.006. Epub 2018 Oct 9. Eur J Radiol. 2018. PMID: 30396665
ANOVA test was performed to assess the differences in volumes between low, intermediate and high-risk groups (Mayo risk score <0, >0 and <2, >2, respectively). Correlations between volumes and Mayo risk score were calcu …
ANOVA test was performed to assess the differences in volumes between low, intermediate and high-risk groups (Mayo risk
Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score.
Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Ni Mhuircheartaigh JM, et al. Abdom Radiol (NY). 2017 Jan;42(1):152-158. doi: 10.1007/s00261-016-0847-z. Abdom Radiol (NY). 2017. PMID: 27472938
The aims of this study are to assess any relationship between peribiliary hyperenhancement on MRI in patients with primary sclerosing cholangitis (PSC) and their Mayo risk score and to assess which timing of peribiliary hyperenhancement correlates best with t …
The aims of this study are to assess any relationship between peribiliary hyperenhancement on MRI in patients with primary sclerosing cholan …
Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?
Jacob DA, Bahra M, Schmidt SC, Schumacher G, Weimann A, Neuhaus P, Neumann UP. Jacob DA, et al. Ann Transplant. 2008;13(3):35-42. Ann Transplant. 2008. PMID: 18806733 Free article.
In order to define the optimal time point for OLT, the Mayo risk score (MRS) was developed and a score of 7.8 was identified for transplantation. ...CONCLUSIONS: The Mayo risk score is an approved mathematical model predicting surv …
In order to define the optimal time point for OLT, the Mayo risk score (MRS) was developed and a score of 7.8 wa …
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.
Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Angulo P, et al. Liver. 1999 Apr;19(2):115-21. doi: 10.1111/j.1478-3231.1999.tb00020.x. Liver. 1999. PMID: 10220741 Clinical Trial.

The Mayo risk score was the single risk factor independently predictive of development of varices (p < 0.01); 93% of patients who developed varices had a Mayo risk score > or = 4. ...A Mayo risk score abo

The Mayo risk score was the single risk factor independently predictive of development of varices (p < 0.01);

Confirmation of the role of the Mayo Risk Score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis.
Gilroy RK, Lynch SV, Strong RW, Kerlin P, Balderson GA, Stuart KA, Crawford DH. Gilroy RK, et al. Liver Transpl. 2000 Nov;6(6):749-52. doi: 10.1053/jlts.2000.9746. Liver Transpl. 2000. PMID: 11084062 Free article.
The Mayo Risk Score has been proposed to help predict optimum time for OLT. We assessed the relation between Mayo risk score, Child-Pugh score, and resource utilization and outcome after OLT for primary biliary cirrhosis. ...Patien …
The Mayo Risk Score has been proposed to help predict optimum time for OLT. We assessed the relation between Mayo
Current and promising therapy for primary biliary cholangitis.
Gossard AA, Lindor KD. Gossard AA, et al. Expert Opin Pharmacother. 2019 Jun;20(9):1161-1167. doi: 10.1080/14656566.2019.1601701. Epub 2019 Apr 22. Expert Opin Pharmacother. 2019. PMID: 30931642 Review.
Several tools such as the Mayo Risk Score and GLOBE are available for prognostic modeling. Ultimately, patients with PBC may end up requiring liver transplantation and referral to a transplant center may also be needed....
Several tools such as the Mayo Risk Score and GLOBE are available for prognostic modeling. Ultimately, patients with PB …
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.
Purohit T, Cappell MS. Purohit T, et al. World J Hepatol. 2015 May 8;7(7):926-41. doi: 10.4254/wjh.v7.i7.926. World J Hepatol. 2015. PMID: 25954476 Free PMC article. Review.
The Mayo Risk score is the most widely used and best prognostic system. Ursodeoxycholic acid is the primary therapy. It works partly by reducing the concentration and injury from relatively toxic bile acids. ...
The Mayo Risk score is the most widely used and best prognostic system. Ursodeoxycholic acid is the primary therapy. It …
Magnetic Resonance Cholangiopancreatography Severity Predicts Disease Outcomes in Pediatric Primary Sclerosing Cholangitis: A Reliability and Validity Study.
Patil K, Ricciuto A, Alsharief A, Al-Rayahi J, Amirabadi A, Church PC, Kamath BM, Greer MC. Patil K, et al. Hepatol Commun. 2019 Dec 6;4(2):208-218. doi: 10.1002/hep4.1454. eCollection 2020 Feb. Hepatol Commun. 2019. PMID: 32025606 Free PMC article.
Six variations of the Majoie classification were examined: 1) intrahepatic duct (IHD) score, 2) extrahepatic duct (EHD) score (representing the worst intrahepatic and extrahepatic regions, respectively), 3) sum IHD-EHD score, 4) average IHD score, 5) a …
Six variations of the Majoie classification were examined: 1) intrahepatic duct (IHD) score, 2) extrahepatic duct (EHD) score
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis.
Dhillon AK, Kremer AE, Kummen M, Boberg KM, Elferink RPO, Karlsen TH, Beuers U, Vesterhus M, Hov JR. Dhillon AK, et al. Sci Rep. 2019 Jun 11;9(1):8450. doi: 10.1038/s41598-019-44762-7. Sci Rep. 2019. PMID: 31186435 Free PMC article.
In a multivariable analysis, high autotaxin activity was associated with an increased risk of liver transplantation or death (hazard ratio 2.03 (95% confidence interval 1.21-3.40), P < 0.01), independent from Mayo risk score, an in-house enhanced li …
In a multivariable analysis, high autotaxin activity was associated with an increased risk of liver transplantation or death (hazard …
153 results
Jump to page
Feedback